181 related articles for article (PubMed ID: 36153509)
21. Establishment of a Nomogram by Integrating Molecular Markers and Tumor-Node-Metastasis Staging System for Predicting the Prognosis of Hepatocellular Carcinoma.
Huang XT; Chen LH; Huang CS; Li JH; Cai JP; Chen W; Yin XY
Dig Surg; 2019; 36(5):426-432. PubMed ID: 30481744
[TBL] [Abstract][Full Text] [Related]
22. Mutation profile and its correlation with clinicopathology in Chinese hepatocellular carcinoma patients.
Wang S; Shi H; Liu T; Li M; Zhou S; Qiu X; Wang Z; Hu W; Guo W; Chen X; Guo H; Shi X; Shi J; Zang Y; Cao J; Wu L
Hepatobiliary Surg Nutr; 2021 Apr; 10(2):172-179. PubMed ID: 33898558
[TBL] [Abstract][Full Text] [Related]
23. Integrating transcriptomes and somatic mutations to identify RNA methylation regulators as a prognostic marker in hepatocellular carcinoma.
Yan Y; Luo YH; Zheng DF; Mu T; Wu ZJ
Hepatobiliary Pancreat Dis Int; 2021 Feb; 20(1):34-45. PubMed ID: 32563589
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive analysis of cell death genes in hepatocellular carcinoma based on multi-omics data.
Zhang L; Chen X; Guo X; Shen H; Qiu D; Jin W; Hou D
Adv Clin Exp Med; 2023 Feb; 32(2):233-244. PubMed ID: 36753369
[TBL] [Abstract][Full Text] [Related]
25. Clinical Impact of Genomic Diversity From Early to Advanced Hepatocellular Carcinoma.
Nault JC; Martin Y; Caruso S; Hirsch TZ; Bayard Q; Calderaro J; Charpy C; Copie-Bergman C; Ziol M; Bioulac-Sage P; Couchy G; Blanc JF; Nahon P; Amaddeo G; Ganne-Carrie N; Morcrette G; Chiche L; Duvoux C; Faivre S; Laurent A; Imbeaud S; Rebouissou S; Llovet JM; Seror O; Letouzé E; Zucman-Rossi J
Hepatology; 2020 Jan; 71(1):164-182. PubMed ID: 31206197
[TBL] [Abstract][Full Text] [Related]
26. A Five-Gene Signature for Recurrence Prediction of Hepatocellular Carcinoma Patients.
Wang Z; Zhang N; Lv J; Ma C; Gu J; Du Y; Qiu Y; Zhang Z; Li M; Jiang Y; Zhao J; Du H; Zhang Z; Lu W; Zhang Y
Biomed Res Int; 2020; 2020():4037639. PubMed ID: 33163533
[TBL] [Abstract][Full Text] [Related]
27. Integrated exome sequencing and microarray analyses detected genetic defects and underlying pathways of hepatocellular carcinoma.
Chong ML; Knight J; Peng G; Ji W; Chai H; Lu Y; Wu S; Li P; Hu Q
Cancer Genet; 2023 Aug; 276-277():30-35. PubMed ID: 37418972
[TBL] [Abstract][Full Text] [Related]
28. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
29. Construction of a disease-specific lncRNA-miRNA-mRNA regulatory network reveals potential regulatory axes and prognostic biomarkers for hepatocellular carcinoma.
Zhang Q; Sun L; Zhang Q; Zhang W; Tian W; Liu M; Wang Y
Cancer Med; 2020 Dec; 9(24):9219-9235. PubMed ID: 33232580
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive analysis of tumour mutation burden and the immune microenvironment in hepatocellular carcinoma.
Xie F; Bai Y; Yang X; Long J; Mao J; Lin J; Wang D; Song Y; Xun Z; Huang H; Yang X; Zhang L; Mao Y; Sang X; Zhao H
Int Immunopharmacol; 2020 Dec; 89(Pt A):107135. PubMed ID: 33189609
[TBL] [Abstract][Full Text] [Related]
31. Overview and clinical significance of multiple mutations in individual genes in hepatocellular carcinoma.
Imamura T; Okamura Y; Ohshima K; Uesaka K; Sugiura T; Ito T; Yamamoto Y; Ashida R; Ohgi K; Otsuka S; Ohnami S; Nagashima T; Hatakeyama K; Sugino T; Urakami K; Akiyama Y; Yamaguchi K
BMC Cancer; 2022 Oct; 22(1):1046. PubMed ID: 36199046
[TBL] [Abstract][Full Text] [Related]
32. Multivariate analysis of several molecular markers and clinicopathological features in postoperative prognosis of hepatocellular carcinoma.
Zuo Q; Huang H; Shi M; Zhang F; Sun J; Bin J; Liao Y; Liao W
Anat Rec (Hoboken); 2012 Mar; 295(3):423-31. PubMed ID: 22190283
[TBL] [Abstract][Full Text] [Related]
33. Identification and validation of a potent multi-mRNA signature for the prediction of early relapse in hepatocellular carcinoma.
Cai J; Tong Y; Huang L; Xia L; Guo H; Wu H; Kong X; Xia Q
Carcinogenesis; 2019 Jul; 40(7):840-852. PubMed ID: 31059567
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Value of MUC16 Mutation and Its Correlation with Immunity in Hepatocellular Carcinoma Patients.
Liu B; Dong Z; Lu Y; Ma J; Ma Z; Wang H
Evid Based Complement Alternat Med; 2022; 2022():3478861. PubMed ID: 36034941
[TBL] [Abstract][Full Text] [Related]
35. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
[TBL] [Abstract][Full Text] [Related]
36. Mutational landscape of combined hepatocellular carcinoma and cholangiocarcinoma, and its clinicopathological significance.
Sasaki M; Sato Y; Nakanuma Y
Histopathology; 2017 Feb; 70(3):423-434. PubMed ID: 27634656
[TBL] [Abstract][Full Text] [Related]
37. Clinical and prognostic value of chaperonin containing T-complex 1 subunit 3 in hepatocellular carcinoma: A Study based on microarray and RNA-sequencing with 4272 cases.
Hou JY; Wu HY; He RQ; Lin P; Dang YW; Chen G
Pathol Res Pract; 2019 Jan; 215(1):177-194. PubMed ID: 30473171
[TBL] [Abstract][Full Text] [Related]
38. Identification and validation of a new gene signature predicting prognosis of hepatocellular carcinoma patients by network analysis of stemness indices.
Cai JL; Zhu GQ; Du JX; Wang B; Wan JL; Xiao K; Dai Z
Expert Rev Gastroenterol Hepatol; 2021 Jun; 15(6):699-709. PubMed ID: 33131341
[No Abstract] [Full Text] [Related]
39. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
40. Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis.
Hsu HC; Jeng YM; Mao TL; Chu JS; Lai PL; Peng SY
Am J Pathol; 2000 Sep; 157(3):763-70. PubMed ID: 10980116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
